1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Native Collective Research Effort to Enhance Wellness (N CREW) Program: Addressing Overdose, Substance Use, Mental Health, and Pain is sponsored by National Center for Advancing Translational Sciences (NCATS), National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH).
This program funds community-led research to enhance culturally grounded, strengths-based, effective, and sustainable interventions addressing overdose, substance use, mental health, and pain in Native communities. While focused on Native communities, many of these are rural and the research focus aligns with the query.
Get alerted about grants like this
Get emailed when new opportunities from “National Center for Advancing Translational Sciences (NCATS), National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
NOT-DA-26-011: Native Collective Research Effort to Enhance Wellness (N CREW) Program: Addressing Overdose, Substance Use, Mental Health, and Pain Native Research Resource Partners Native Collective Research Effort to Enhance Wellness (N CREW) Program: Addressing Overdose, Substance Use, Mental Health, and Pain – Native Research Resource Partners June 23, 2023 - HEAL Initiative: Phase I Native Collective Research Effort to Enhance Wellness (N CREW) Program - Addressing Overdose, Substance Use, Mental Health, and Pain (OT2).
See ROA OTA-23-007 . June 23, 2023 - HEAL Initiative: Phase I Native Collective Research Effort to Enhance Wellness (N CREW) Program - Addressing Overdose, Substance Use, Mental Health, and Pain Native Research Resource Network (OT2). See ROA OTA-23-008 .
National Institute on Drug Abuse ( NIDA ) National Institute of Neurological Disorders and National Institute on Minority Health and Health Disparities ( NIMHD ) National Center for Advancing Translational Sciences ( NCATS ) This Notice is to announce the publication of a Research Opportunity Announcement (ROA) for Phase II of the Native Collective Research Effort to Enhance Wellness (N CREW) Program: Addressing Overdose, Substance Use, Mental Health, and Pain – Native Research Resource Partners.
This program is funded by the NIH HEAL Initiative®. Applications are due July 31, 2026. ROA OTA-26-002 solicits applications from Tribes & Native Serving Organizations (T/NSOs) and Ally Organizations to serve as Native Research Resource Partners (NRRPs) to T/NSOs funded under ROA OTA-26-001.
NRRP Key functions include, but are not limited to, N CREW Network coordination and management; training and technical assistance; supporting N CREW data initiatives; collaboration across the N CREW Network, and evaluation. ROA OTA-26-001 solicits applications from T/NSOs to conduct community-led research projects. The research must explicitly include a focus on overdose, substance use (including opioids or stimulants), or pain.
Projects may also include related factors such as mental health or wellness, among others, to support positive health outcomes in Native communities. NIH will hold a series of informational webinars. Webinar details, including dates and registration links, will be posted online on the N CREW Program website .
Potential applicants will be encouraged to email questions to [email protected] . The N CREW Program website will be routinely updated with new Questions and Answers and Technical Assistance information.
Please direct all inquiries to: Scientific/Research inquiries: National Institute on Drug Abuse (NIDA) Financial/Agreements Officer inquiries: National Center for Advancing Translational Science (NCATS) Weekly TOC for this Announcement NIH... Turning Discovery Into Health ®
According to the current listing, eligibility includes: Organizations involved in community-led research in Native communities. Confirm the full requirements in the official notice before applying.
The published deadline was July 31, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Native Collective Research Effort to Enhance Wellness (N CREW) Program: Addressing Overdose, Substance Use, Mental Health, and Pain is funded by National Center for Advancing Translational Sciences (NCATS), National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.
The HEAL Initiative's Studies to Enable Analgesic Discovery award (RFA-NS-25-023) puts federal money exactly where private capital won't go — the assay-building, screening, and hit-characterization stage of non-opioid pain therapeutics. It's a phased R61/R33, up to $350,000 in direct costs per year, with the next application deadline September 17, 2026. Here is how the two-phase structure works, who's eligible, and how to build a proposal that survives the R61-to-R33 milestone gate.
Read articleAdvance from NIH SBIR Phase I to Phase II with tips on demonstrating feasibility, building a commercialization plan, and securing $1M in funding.
Read articleAfter a rare gap with zero active omnibus NOFOs, NIH has reissued its SBIR/STTR parent announcements — collapsing four solicitations into two, adding a Strategic Breakthrough bridge and a Commercialization Readiness Pilot, and reopening the funnel with a September 5, 2026 receipt date. Here are the exact solicitation numbers, the new budget ceilings, what actually changed, and how a small business should sequence its submission.
Read article